Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Diabetes Monitoring Start-Ups:Building a Better Mousetrap or a Whole New Paradigm?

This article was originally published in Start Up

Executive Summary

All facets of diabetes are a big focus of start-up and venture capital interest these days--insulin, blood-glucose testing, and new small-molecule drugs. Blood glucose monitoring is one of the few areas of in vitro diagnostics that attracts a significant amount of investor interest. Startups in this field pick one of two tacts: to try to change the testing paradigm with revolutionary technologies or to introduce incremental improvements, which could help attract big corporate partners.

Related Content


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts